| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/21/2006 | EP1670819A1 A novel conotoxin modulating sodium channels |
| 06/21/2006 | EP1670818A2 Piscirickettsia salmonis antigens and use thereof |
| 06/21/2006 | EP1670817A2 Uses of spatial configuration to modulate protein function |
| 06/21/2006 | EP1670815A2 Melanocortin receptor agonists |
| 06/21/2006 | EP1670813A2 Rho antibody and tag to purify cell surface proteins |
| 06/21/2006 | EP1670511A2 Cripto antagonism of activin and tgf-b signaling |
| 06/21/2006 | EP1670510A1 Antibodies against annexins, use thereof for therapy and diagnosis. use of annexins for therapy and diagnosis. |
| 06/21/2006 | EP1670509A2 Multiplex vaccines |
| 06/21/2006 | EP1670508A2 Compositions, methods and kits relating to poxvirus subunit vaccines |
| 06/21/2006 | EP1670507A2 Vaccine for treatment and prevention of herpes simplex virus infection |
| 06/21/2006 | EP1670505A2 Dna promoters and anthrax vaccines |
| 06/21/2006 | EP1670504A1 Vaccines containingthe hiv tat protein as an adjuvant for the enhancement of cytotoxic t-cell responses |
| 06/21/2006 | EP1670500A2 Compositions capable of facilitating penetration across a biological barrier |
| 06/21/2006 | EP1670499A2 Methods for treating cardiovascular disease using a soluble ctla4 molecule |
| 06/21/2006 | EP1670498A1 p185 neu -ENCODING DNA AND THERAPEUTICAL USES THEREOF |
| 06/21/2006 | EP1670428A2 G-csf transferrin fusion proteins |
| 06/21/2006 | EP1670425A2 Bone morphogenetic protein (bmp) 2a and uses thereof |
| 06/21/2006 | EP1670415A2 Animal model for protease activity and liver damage |
| 06/21/2006 | EP1670413A2 Method of reducing visceral fat by increasing levels of insulin-like growth factor-i (igf-i) |
| 06/21/2006 | EP1670350A2 Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer |
| 06/21/2006 | EP1670309A1 Transgenic animals with serious disorders related to alzheimer's disease |
| 06/21/2006 | EP1670308A1 Chimeric cancer models |
| 06/21/2006 | EP1573032A4 Human il-18 crystal structure |
| 06/21/2006 | EP1536822B1 Stable pharmaceutical composition comprising erythropoietin |
| 06/21/2006 | EP1504106A4 Method of increasing plant organ and seed size in a plant |
| 06/21/2006 | EP1456233A4 Haemocyanin from abalone and process of purification thereof |
| 06/21/2006 | EP1434589A4 Thioester-terminated water soluble polymers and method of modifying the n-terminus of a polypeptide therewith |
| 06/21/2006 | EP1420646B1 Antimicrobial agent |
| 06/21/2006 | EP1326895B8 Monoclonal antibodies directed against hepatitis b viruses |
| 06/21/2006 | EP1252315B1 Method for the production of a protein |
| 06/21/2006 | EP1189931B1 Peptide compounds that bind her2 |
| 06/21/2006 | EP1119773B8 Assay for disease related conformation of a protein |
| 06/21/2006 | EP1042363B1 Novel anti-hiv immunogens (toxoids), preparation methods and use for preventing and treating aids |
| 06/21/2006 | EP1019433B1 Protein composition and process for isolating a protein composition from a muscle source |
| 06/21/2006 | EP0934416B1 Feline polynucleotide vaccine formula |
| 06/21/2006 | EP0932626B1 G protein-coupled receptor antagonists |
| 06/21/2006 | EP0914342B1 Polymeric somatostatin derivatives useful for promoting body growth |
| 06/21/2006 | EP0909564B1 Erythropoietin solution preparation stabilized with amino acids |
| 06/21/2006 | EP0830456B1 ISOLATED FrpB NUCLEIC ACID MOLECULE AND VACCINE |
| 06/21/2006 | EP0778888B1 Antigenically-marked non-infectious retrovirus-like particles |
| 06/21/2006 | EP0754231B1 Peptide fragment of the respiratory syncytial virus g protein, immunogenic agent, pharmaceutical composition containing same, and preparation method |
| 06/21/2006 | CN1791679A Gene therapy vectors having reduced immunogenicity based on CD8 alpha-chain |
| 06/21/2006 | CN1791678A Improved alphavirus replicons and helper constructs |
| 06/21/2006 | CN1791676A Method for the preparation of transgenic plants characterised by geminivirus lasting resistance |
| 06/21/2006 | CN1791613A Analysis and use of par1 polymorphisms for evaluating the risk of cardiovascular disorders |
| 06/21/2006 | CN1791612A Novel antimicrobial peptides with heparin binding activity |
| 06/21/2006 | CN1791427A Method and composition of a novel vaccine design for the prevention and treatment of SARS |
| 06/21/2006 | CN1791421A Method for inducing mammary epithelial cell differentiation |
| 06/21/2006 | CN1789412A Reconstruction of 5-enol pyruvoyl shikimic acid-3-phosphate synthetase activity by utilizing fragment complementation technique |
| 06/21/2006 | CN1789411A Isolated nucleic acid molecules which encode T cell inducible factors (TIF), the proteins encoded, and uses thereof |
| 06/21/2006 | CN1789283A Artificial antigen, antibody of fenvalerate and uses thereof |
| 06/21/2006 | CN1789282A Multifunctional polypeptide |
| 06/21/2006 | CN1789281A Synthesis method of 3 beta protein of pig ovum pellucid zone |
| 06/21/2006 | CN1789280A PHD transcription factor of soybean and its coding gene and usage |
| 06/21/2006 | CN1789276A One-step purification method of recombined human osteogenesis protein -1 |
| 06/21/2006 | CN1260367C Fortified fusion protein possessing angiopoiesis-inhibiting and anti-tumour actions |
| 06/21/2006 | CN1260362C Method for separating and identifying flower pesticide specific promoter of cotton |
| 06/21/2006 | CN1260359C High-solublity expressed tricholsanthin mutant and its preparing method |
| 06/21/2006 | CN1260358C cDNA segment of controlling growth of microspore of paddy, coded result and application |
| 06/21/2006 | CN1260251C Transcription factor for regulating and controlling gibberellin generation, coded gene and application thereof |
| 06/21/2006 | CN1260250C Preparation method of thymopentapeptide |
| 06/20/2006 | US7064249 Plants transformed to express Cry2A δ-endotoxins |
| 06/20/2006 | US7064248 Method of preparing fertile transgenic corn plants by microprojectile bombardment |
| 06/20/2006 | US7064244 Transgenic mammals having human Ig loci including plural VH and VK regions and antibodies produced therefrom |
| 06/20/2006 | US7064195 Fusion proteins of mycobacterium tuberculosis antigens and their uses |
| 06/20/2006 | US7064194 Vectors for animal cells and utilization thereof |
| 06/20/2006 | US7064193 Therapeutic molecules |
| 06/20/2006 | US7064190 An isolated complex of a peptide of glutamic acid decarboxylase(with specific 6 contiguous amino acids), and an allele of MHC class II molecules DR3 and DR4; useful for diagnosis and therapy of autoimmune diseases |
| 06/20/2006 | US7064186 Comprises chemokine polypeptides for diagnosis, prevention and treatment of cell proliferative, immunological and hematopoietic disorders |
| 06/20/2006 | US7064185 Antibody for human Cyr61 |
| 06/20/2006 | US7064184 Use in impacting plant microbial pathogens and in enhancing plant disease resistance to microbial pathogens |
| 06/20/2006 | US7064183 Use in impacting plant microbial pathogens and in enhancing plant disease resistance to microbial pathogens |
| 06/20/2006 | US7064182 A polypeptide with serine protease inhibition activity |
| 06/20/2006 | US7064181 A nonapeptide containing an amino acid sequence: ala, pro, ala, his, arg, gly, arg, gly, gly, amide, ester or salt; ability to bind to a receptor protein of specific sequence |
| 06/20/2006 | US7064180 High affinity integrin polypeptides and uses thereof |
| 06/20/2006 | US7064107 Prevention and reduction of blood loss |
| 06/20/2006 | US7064106 Protein, as a reagent for screening a compound that inhibit the binding of the protein to insulin responsive aminopeptidase or to glucose transporter 4; useful as a preventive/remedy for hyperglycemia and diabetes melliuts etc. |
| 06/20/2006 | US7063972 Cytochrome P450 monooxygenase CYP52A2A from Candida tropicalis |
| 06/20/2006 | US7063966 Quantitative analysis; complexing with antibodies |
| 06/20/2006 | US7063965 especially that encodes an immunoglobulin constant region such as the Fc portion of human IgG1. |
| 06/20/2006 | US7063963 Nucleotide sequences consisiting of DNA viral open reading frames which code proteins which can be used to prepare genetic vaccines which prevent viral diseases |
| 06/20/2006 | US7063961 Having enhanced affinity for the ErbB-3 and ErbB-4 receptors; enhancing survival, proliferation, of differentiation cells. |
| 06/20/2006 | US7063960 Interacting the immature dendritic cels with an antigen ex vivo so that the surface antigen is presented; inducing maturation ex vivo; and contacting with a modulator comprising TRANCE or derivative |
| 06/20/2006 | US7063958 that encode a receptor for leptin, including a naturally occurring soluble form of the receptor that is expected to modulate, especially agonize, leptin activity; could be used to treat obesity |
| 06/20/2006 | US7063953 Human voltage gated sodium channel β1A subunit and methods of use |
| 06/20/2006 | US7063951 Members of the capsaicin/vanilloid receptor family of proteins and uses thereof |
| 06/20/2006 | US7063950 Nucleic acids encoding human calcium channel and methods of use thereof |
| 06/20/2006 | US7063949 Methods for isolating molecular mimetics of unique Neisseria meningitidis serogroup B epitopes |
| 06/20/2006 | US7063854 Polypeptide comprising the immunogenic portion of wilms' tumor suppressor gene(wt1); tumor-associated antigen for use in cancer immunotherapy |
| 06/20/2006 | US7063853 DNA immunization against Chlamydia infection |
| 06/20/2006 | US7063849 Use of HIV-1 gp120 and gp160 proteins modified in the v3 loop for the preparation of vaccine compositions and formulations containing the same |
| 06/20/2006 | US7063847 Compositions and methods for enhancing immune responses mediated by antigen-presenting cells |
| 06/20/2006 | US7063846 Purified or isolated antibody that binds to said outer membrane proteins; accurate diagnosis of ehrlichiosis |
| 06/20/2006 | US7063844 Presentation of hydrophobic antigens to T-cells by CD1 molecules |
| 06/20/2006 | US7063843 Cloning and regulation of an endothelial cell protein C/activated protein C receptor |
| 06/20/2006 | US7063842 Compounds and methods for inhibiting the interaction between α-catenin and β-catenin |
| 06/20/2006 | US7063841 Mammalian cell surface antigens; related reagents |
| 06/20/2006 | US7063840 Genes for receptor tyrosine kinases and their cognate ligands, their insertion into genetic engineered DNA vectors; useful in the diagnosis and treatment of neoplastic diseases |
| 06/20/2006 | US7063829 Wasp family protein fragments, and use thereof |
| 06/20/2006 | CA2260423C Pharmaceutical composition of hedgehog proteins and use thereof |